Gary A. Zarkin
Vice President, Behavioral Health and Criminal Justice
Gary A. Zarkin, PhD, has led or participated in several projects involving the economic analysis of drug treatment, prevention, and studies of workplace substance abuse. Dr. Zarkin has published several papers on the cost, cost-effectiveness, and the benefit-cost of substance abuse interventions. He is currently the PI on a grant funded by NIAAA to estimate the cost and cost-effectiveness of the COMBINE intervention, and he is the project director of the State Outcomes Measurement and Management System contract with SAMHSA. He previously led the development of a new method to estimate the cost of services for methadone treatment. Before coming to RTI, Dr. Zarkin was an assistant professor of economics and a research associate professor of statistics at Duke University. He has published on economics, substance abuse, and health service topics in a wide range of professional journals.
PhD, Economics, University of Chicago; MA, Economics, University of Chicago; BA, Economics, University of Washington.
- Substance Abuse Economics
- Cost Analysis and Cost-Effectiveness
- Cost-Benefit Analysis